COBAS AMPLISCREEN HBV TEST 03599779190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2014-04-25 for COBAS AMPLISCREEN HBV TEST 03599779190 manufactured by Roche Molecular Systems.

Event Text Entries

[16915939] A customer in the us filed a complaint alleging that result discrepancies were generated for one patient sample with the cobas ampliscreen (cas) (b)(6) test in two separate runs as well as discrepancies when compared with eia testing with ortho and prism platforms. The cas (b)(6) test generated reactive and (b)(6) results in two runs. The eia testing with ortho generated a (b)(6) result. The eia testing with prism generated a reactive result. The donor sample was rejected and not released for donation.
Patient Sequence No: 1, Text Type: D, B5


[17089452] A definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of this investigation will be communicated through a follow-up report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[34940052] Date of report may 21, 2014. Date of receipt by manufacturer may 21, 2014. Follow up report 1. Device evaluated by manufacturer yes. Result: device performed according to specification; conclusion: no failure detected and product within specifications. The complaint alleged that result discrepancies were generated for one patient sample with the cobas ampliscreen (cas) (b)(6) test in two separate runs as well as discrepancies when compared with eia testing with ortho and prism platforms. The cas (b)(6) test generated reactive and non-reactive results in two runs. The eia testing with ortho generated a non- reactive result. The eia testing with prism generated a reactive result. The donor sample was rejected and not released for donation. Although requested, no sample was available for further investigation; without investigating the complaint sample, the root cause for the discrepant results cannot be identified. It is possible that the discrepant results seen between the cas test runs could be due to the presence of a low hbv viral titer that is near the lod of the cas test. However this cannot be confirmed. Retain testing of cas complaint batch generated valid acceptable results. No false non-reactive results were generated during testing. All results met qc release validation and acceptance criteria. These results confirm the complaint kit batch is performing as intended (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2014-00009
MDR Report Key3772187
Report Source05
Date Received2014-04-25
Date of Report2014-05-21
Date of Event2014-03-18
Date Mfgr Received2014-05-21
Date Added to Maude2014-06-19
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS AMPLISCREEN HBV TEST
Generic NameHBV NUCLEIC ACID AMPLIFICATION AND DETECTION
Product CodeMKT
Date Received2014-04-25
Catalog Number03599779190
Lot NumberS07522
Device Expiration Date2014-07-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2014-04-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.